- Home
- Publications
- Publication Search
- Publication Details
Title
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases
Authors
Keywords
-
Journal
HYPERTENSION
Volume 76, Issue 3, Pages 651-661
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-08-13
DOI
10.1161/hypertensionaha.120.15595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission
- (2020) Yuan Tian et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
- (2020) Huilan Zhang et al. ANNALS OF INTERNAL MEDICINE
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19
- (2020) Aashish Manglik et al. CIRCULATION
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Angiotensin Converting Enzyme 2 and Angiotensin (1–7) axis in Pulmonary Arterial Hypertension
- (2020) Julio Sandoval et al. EUROPEAN RESPIRATORY JOURNAL
- Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process
- (2020) Hao Zhang et al. GUT
- Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension
- (2020) Seungbum Kim et al. HYPERTENSION
- Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension
- (2020) Ravindra K. Sharma et al. HYPERTENSION
- Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
- (2020) Yu-Han Xing et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Mechanisms by which angiotensin-receptor blockers increase ACE2 levels
- (2020) Carlos M. Ferrario et al. Nature Reviews Cardiology
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
- (2020) Silan Gu et al. CLINICAL INFECTIOUS DISEASES
- Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review
- (2020) V. Montalvan et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust
- (2020) Daniel M. Bean et al. EUROPEAN JOURNAL OF HEART FAILURE
- Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice
- (2020) Amrisha Verma et al. Molecular Therapy-Methods & Clinical Development
- Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension
- (2019) Ravindra K Sharma et al. CIRCULATION RESEARCH
- Microbes, metabolites, and the gut–lung axis
- (2019) Anh Thu Dang et al. Mucosal Immunology
- Pulmonary artery denervation: a novel treatment modality for pulmonary hypertension
- (2019) Trixie Le et al. Journal of Thoracic Disease
- Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency
- (2019) Yaqian Duan et al. CIRCULATION RESEARCH
- ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway
- (2019) Rensong Ye et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension
- (2018) Anna R. Hemnes et al. EUROPEAN RESPIRATORY JOURNAL
- Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary HypertensionNovelty and Significance
- (2018) Ravindra K. Sharma et al. HYPERTENSION
- Involvement of Microglial Cells in Hypoxia-induced Pulmonary Hypertension
- (2018) Aline C. Oliveira et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A metagenome-wide association study of gut microbiota in asthma in UK adults
- (2018) Qi Wang et al. BMC MICROBIOLOGY
- Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
- (2017) Ratnadeep Basu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy
- (2017) Larissa B. Teixeira et al. Scientific Reports
- A Paradigm Shift Is Needed in the Field of Pulmonary Arterial Hypertension for Its Entrance Into the Precision Medicine Era
- (2016) Vikram Gurtu et al. CIRCULATION RESEARCH
- Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors
- (2016) Lei Wang et al. NEUROPHARMACOLOGY
- Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice
- (2015) Lifang Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Angiotensin-Converting Enzyme 2 Inhibits Apoptosis of Pulmonary Endothelial Cells During Acute Lung Injury Through Suppressing SMAD2 Phosphorylation
- (2015) Yong Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression
- (2014) Shiori Haga et al. EXPERIMENTAL LUNG RESEARCH
- Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension
- (2014) Vinayak Shenoy et al. HYPERTENSION
- Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus
- (2014) Xin Liu et al. VIRUS RESEARCH
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
- (2014) Zhen Zou et al. Nature Communications
- Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
- (2013) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diminazene aceturate improves autonomic modulation in pulmonary hypertension
- (2013) Katya Rigatto et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Diminazene Aceturate Enhances Angiotensin-Converting Enzyme 2 Activity and Attenuates Ischemia-Induced Cardiac Pathophysiology
- (2013) YanFei Qi et al. HYPERTENSION
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
- (2013) Thomas Perlot et al. MICROBES AND INFECTION
- Upregulation of ACE2-ANG-(1–7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport
- (2012) Tung Po Wong et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Intestinal peptidases form functional complexes with the neutral amino acid transporter B0AT1
- (2012) Stephen J. Fairweather et al. BIOCHEMICAL JOURNAL
- Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction
- (2012) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes
- (2012) Chris Tikellis et al. CLINICAL SCIENCE
- Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury
- (2012) G. J. Rey-Parra et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
- (2012) Tatsuo Hashimoto et al. NATURE
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
- (2011) Roelie M Wösten-van Asperen et al. JOURNAL OF PATHOLOGY
- The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension
- (2010) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
- Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets
- (2010) Benedikt Treml et al. CRITICAL CARE MEDICINE
- Brain Microglial Cytokines in Neurogenic Hypertension
- (2010) Peng Shi et al. HYPERTENSION
- Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension
- (2009) Anderson J. Ferreira et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem
- (2009) Jeremy PT Ward et al. CURRENT OPINION IN PHARMACOLOGY
- Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer
- (2009) Yoriko Yamazato et al. HYPERTENSION
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2
- (2009) Jan Wysocki et al. HYPERTENSION
- Pulmonary fibrosis: pathogenesis, etiology and regulation
- (2009) M S Wilson et al. Mucosal Immunology
- Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis
- (2008) Xiaopeng Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Structure and Mechanism of Metallocarboxypeptidases
- (2008) F. Gomis-Rüth CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search